TY  - JOUR
AU  - Frutos-López, Manuel
AU  - Pedrote, Alonso
AU  - Acosta-Martínez, Juan
AU  - Arana-Rueda, Eduardo
PY  - 2020
DO  - 10.1016/j.repc.2017.11.018
UR  - http://hdl.handle.net/10668/15435
T2  - Revista portuguesa de cardiologia
AB  - Antiarrhythmic drugs are often the last resort for recurrent ventricular tachycardia refractory to catheter ablation in implantable cardioverter-defibrillator carriers. Amiodarone, alone or combined with mexiletine, is usually but not always highly...
LA  - en
KW  - Ablação por cateter
KW  - Antiarrhythmic drugs
KW  - Arritmias ventriculares
KW  - Catheter ablation
KW  - Dronedarona
KW  - Dronedarone
KW  - Fármacos anti-arrítmicos
KW  - Mexiletina
KW  - Mexiletine
KW  - Ventricular arrhythmias
KW  - Amiodarone
KW  - Anti-Arrhythmia Agents
KW  - Catheter Ablation
KW  - Defibrillators, Implantable
KW  - Dronedarone
KW  - Drug Therapy, Combination
KW  - Humans
KW  - Male
KW  - Mexiletine
KW  - Middle Aged
KW  - Tachycardia, Ventricular
KW  - Treatment Outcome
TI  - Dramatic reduction of ventricular tachycardia burden after dronedarone plus mexiletine treatment in a patient refractory to hybrid ablation.
TY  - research article
VL  - 39
ER  -